Global Superdisintegrants Industry

Global Superdisintegrants Market to Reach $649. 7 Million by 2027. Amid the COVID-19 crisis, the global market for Superdisintegrants estimated at US$413. 7 Million in the year 2020, is projected to reach a revised size of US$649.

New York, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Superdisintegrants Industry" - https://www.reportlinker.com/p05960207/?utm_source=GNW
7 Million by 2027, growing at a CAGR of 6.7% over the analysis period 2020-2027. Natural Superdisintegrants, one of the segments analyzed in the report, is projected to record a 6.6% CAGR and reach US$229 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Synthetic Superdisintegrants segment is readjusted to a revised 7.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $111.9 Million, While China is Forecast to Grow at 10.1% CAGR

The Superdisintegrants market in the U.S. is estimated at US$111.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$140.7 Million by the year 2027 trailing a CAGR of 10.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 5.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Other Products Segment to Record 5.8% CAGR

In the global Other Products segment, USA, Canada, Japan, China and Europe will drive the 5.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$73.9 Million in the year 2020 will reach a projected size of US$106.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$88.6 Million by the year 2027, while Latin America will expand at a 7% CAGR through the analysis period. We bring years of research experience to this 6th edition of our report. The 289-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

• Asahi Kasei Corporation

• Ashland Global Holdings, Inc.

• Avantor Performance Materials LLC

• BASF SE

• Corel Pharma Chem

• DFE Pharma GmbH & Co. KG

• DowDuPont, Inc.

• Jrs Pharma GmbH Co. KG

• Merck KgaA

• Roquette Freres S.A.

Read the full report: https://www.reportlinker.com/p05960207/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Superdisintegrants Competitor Market Share Scenario Worldwide
(in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Superdisintegrants
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 2: World Historic Review for Superdisintegrants by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 3: World 15-Year Perspective for Superdisintegrants by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Natural
Superdisintegrants by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027

Table 5: World Historic Review for Natural Superdisintegrants
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 6: World 15-Year Perspective for Natural
Superdisintegrants by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 7: World Current & Future Analysis for Synthetic
Superdisintegrants by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027

Table 8: World Historic Review for Synthetic Superdisintegrants
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 9: World 15-Year Perspective for Synthetic
Superdisintegrants by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 10: World Current & Future Analysis for Other Products by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 11: World Historic Review for Other Products by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 12: World 15-Year Perspective for Other Products by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Gastrointestinal
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 14: World Historic Review for Gastrointestinal by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 15: World 15-Year Perspective for Gastrointestinal by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Cardiovascular by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 17: World Historic Review for Cardiovascular by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 18: World 15-Year Perspective for Cardiovascular by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Neurology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 20: World Historic Review for Neurology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 21: World 15-Year Perspective for Neurology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Oncology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 23: World Historic Review for Oncology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 24: World 15-Year Perspective for Oncology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Other Therapeutic
Areas by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 26: World Historic Review for Other Therapeutic Areas by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 27: World 15-Year Perspective for Other Therapeutic Areas
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Superdisintegrants Market Share (in %) by Company: 2019 & 2025
Market Analytics
Table 28: USA Current & Future Analysis for Superdisintegrants
by Product - Natural Superdisintegrants, Synthetic
Superdisintegrants and Other Products - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 29: USA Historic Review for Superdisintegrants by Product -
Natural Superdisintegrants, Synthetic Superdisintegrants and
Other Products Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019

Table 30: USA 15-Year Perspective for Superdisintegrants by
Product - Percentage Breakdown of Value Sales for Natural
Superdisintegrants, Synthetic Superdisintegrants and Other
Products for the Years 2012, 2020 & 2027

Table 31: USA Current & Future Analysis for Superdisintegrants
by Therapeutic Area - Gastrointestinal, Cardiovascular,
Neurology, Oncology and Other Therapeutic Areas - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 32: USA Historic Review for Superdisintegrants by
Therapeutic Area - Gastrointestinal, Cardiovascular, Neurology,
Oncology and Other Therapeutic Areas Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 33: USA 15-Year Perspective for Superdisintegrants by
Therapeutic Area - Percentage Breakdown of Value Sales for
Gastrointestinal, Cardiovascular, Neurology, Oncology and Other
Therapeutic Areas for the Years 2012, 2020 & 2027

CANADA
Table 34: Canada Current & Future Analysis for
Superdisintegrants by Product - Natural Superdisintegrants,
Synthetic Superdisintegrants and Other Products - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 35: Canada Historic Review for Superdisintegrants by
Product - Natural Superdisintegrants, Synthetic
Superdisintegrants and Other Products Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 36: Canada 15-Year Perspective for Superdisintegrants by
Product - Percentage Breakdown of Value Sales for Natural
Superdisintegrants, Synthetic Superdisintegrants and Other
Products for the Years 2012, 2020 & 2027

Table 37: Canada Current & Future Analysis for
Superdisintegrants by Therapeutic Area - Gastrointestinal,
Cardiovascular, Neurology, Oncology and Other Therapeutic Areas -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 38: Canada Historic Review for Superdisintegrants by
Therapeutic Area - Gastrointestinal, Cardiovascular, Neurology,
Oncology and Other Therapeutic Areas Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 39: Canada 15-Year Perspective for Superdisintegrants by
Therapeutic Area - Percentage Breakdown of Value Sales for
Gastrointestinal, Cardiovascular, Neurology, Oncology and Other
Therapeutic Areas for the Years 2012, 2020 & 2027

JAPAN
Table 40: Japan Current & Future Analysis for
Superdisintegrants by Product - Natural Superdisintegrants,
Synthetic Superdisintegrants and Other Products - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 41: Japan Historic Review for Superdisintegrants by
Product - Natural Superdisintegrants, Synthetic
Superdisintegrants and Other Products Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 42: Japan 15-Year Perspective for Superdisintegrants by
Product - Percentage Breakdown of Value Sales for Natural
Superdisintegrants, Synthetic Superdisintegrants and Other
Products for the Years 2012, 2020 & 2027

Table 43: Japan Current & Future Analysis for
Superdisintegrants by Therapeutic Area - Gastrointestinal,
Cardiovascular, Neurology, Oncology and Other Therapeutic Areas -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 44: Japan Historic Review for Superdisintegrants by
Therapeutic Area - Gastrointestinal, Cardiovascular, Neurology,
Oncology and Other Therapeutic Areas Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 45: Japan 15-Year Perspective for Superdisintegrants by
Therapeutic Area - Percentage Breakdown of Value Sales for
Gastrointestinal, Cardiovascular, Neurology, Oncology and Other
Therapeutic Areas for the Years 2012, 2020 & 2027

CHINA
Table 46: China Current & Future Analysis for
Superdisintegrants by Product - Natural Superdisintegrants,
Synthetic Superdisintegrants and Other Products - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 47: China Historic Review for Superdisintegrants by
Product - Natural Superdisintegrants, Synthetic
Superdisintegrants and Other Products Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 48: China 15-Year Perspective for Superdisintegrants by
Product - Percentage Breakdown of Value Sales for Natural
Superdisintegrants, Synthetic Superdisintegrants and Other
Products for the Years 2012, 2020 & 2027

Table 49: China Current & Future Analysis for
Superdisintegrants by Therapeutic Area - Gastrointestinal,
Cardiovascular, Neurology, Oncology and Other Therapeutic Areas -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 50: China Historic Review for Superdisintegrants by
Therapeutic Area - Gastrointestinal, Cardiovascular, Neurology,
Oncology and Other Therapeutic Areas Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 51: China 15-Year Perspective for Superdisintegrants by
Therapeutic Area - Percentage Breakdown of Value Sales for
Gastrointestinal, Cardiovascular, Neurology, Oncology and Other
Therapeutic Areas for the Years 2012, 2020 & 2027

EUROPE
Market Facts & Figures
European Superdisintegrants Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Market Analytics
Table 52: Europe Current & Future Analysis for
Superdisintegrants by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 53: Europe Historic Review for Superdisintegrants by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 54: Europe 15-Year Perspective for Superdisintegrants by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 55: Europe Current & Future Analysis for
Superdisintegrants by Product - Natural Superdisintegrants,
Synthetic Superdisintegrants and Other Products - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 56: Europe Historic Review for Superdisintegrants by
Product - Natural Superdisintegrants, Synthetic
Superdisintegrants and Other Products Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 57: Europe 15-Year Perspective for Superdisintegrants by
Product - Percentage Breakdown of Value Sales for Natural
Superdisintegrants, Synthetic Superdisintegrants and Other
Products for the Years 2012, 2020 & 2027

Table 58: Europe Current & Future Analysis for
Superdisintegrants by Therapeutic Area - Gastrointestinal,
Cardiovascular, Neurology, Oncology and Other Therapeutic Areas -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 59: Europe Historic Review for Superdisintegrants by
Therapeutic Area - Gastrointestinal, Cardiovascular, Neurology,
Oncology and Other Therapeutic Areas Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 60: Europe 15-Year Perspective for Superdisintegrants by
Therapeutic Area - Percentage Breakdown of Value Sales for
Gastrointestinal, Cardiovascular, Neurology, Oncology and Other
Therapeutic Areas for the Years 2012, 2020 & 2027

FRANCE
Table 61: France Current & Future Analysis for
Superdisintegrants by Product - Natural Superdisintegrants,
Synthetic Superdisintegrants and Other Products - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 62: France Historic Review for Superdisintegrants by
Product - Natural Superdisintegrants, Synthetic
Superdisintegrants and Other Products Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 63: France 15-Year Perspective for Superdisintegrants by
Product - Percentage Breakdown of Value Sales for Natural
Superdisintegrants, Synthetic Superdisintegrants and Other
Products for the Years 2012, 2020 & 2027

Table 64: France Current & Future Analysis for
Superdisintegrants by Therapeutic Area - Gastrointestinal,
Cardiovascular, Neurology, Oncology and Other Therapeutic Areas -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 65: France Historic Review for Superdisintegrants by
Therapeutic Area - Gastrointestinal, Cardiovascular, Neurology,
Oncology and Other Therapeutic Areas Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 66: France 15-Year Perspective for Superdisintegrants by
Therapeutic Area - Percentage Breakdown of Value Sales for
Gastrointestinal, Cardiovascular, Neurology, Oncology and Other
Therapeutic Areas for the Years 2012, 2020 & 2027

GERMANY
Table 67: Germany Current & Future Analysis for
Superdisintegrants by Product - Natural Superdisintegrants,
Synthetic Superdisintegrants and Other Products - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 68: Germany Historic Review for Superdisintegrants by
Product - Natural Superdisintegrants, Synthetic
Superdisintegrants and Other Products Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 69: Germany 15-Year Perspective for Superdisintegrants by
Product - Percentage Breakdown of Value Sales for Natural
Superdisintegrants, Synthetic Superdisintegrants and Other
Products for the Years 2012, 2020 & 2027

Table 70: Germany Current & Future Analysis for
Superdisintegrants by Therapeutic Area - Gastrointestinal,
Cardiovascular, Neurology, Oncology and Other Therapeutic Areas -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 71: Germany Historic Review for Superdisintegrants by
Therapeutic Area - Gastrointestinal, Cardiovascular, Neurology,
Oncology and Other Therapeutic Areas Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 72: Germany 15-Year Perspective for Superdisintegrants by
Therapeutic Area - Percentage Breakdown of Value Sales for
Gastrointestinal, Cardiovascular, Neurology, Oncology and Other
Therapeutic Areas for the Years 2012, 2020 & 2027

ITALY
Table 73: Italy Current & Future Analysis for
Superdisintegrants by Product - Natural Superdisintegrants,
Synthetic Superdisintegrants and Other Products - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 74: Italy Historic Review for Superdisintegrants by
Product - Natural Superdisintegrants, Synthetic
Superdisintegrants and Other Products Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 75: Italy 15-Year Perspective for Superdisintegrants by
Product - Percentage Breakdown of Value Sales for Natural
Superdisintegrants, Synthetic Superdisintegrants and Other
Products for the Years 2012, 2020 & 2027

Table 76: Italy Current & Future Analysis for
Superdisintegrants by Therapeutic Area - Gastrointestinal,
Cardiovascular, Neurology, Oncology and Other Therapeutic Areas -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 77: Italy Historic Review for Superdisintegrants by
Therapeutic Area - Gastrointestinal, Cardiovascular, Neurology,
Oncology and Other Therapeutic Areas Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 78: Italy 15-Year Perspective for Superdisintegrants by
Therapeutic Area - Percentage Breakdown of Value Sales for
Gastrointestinal, Cardiovascular, Neurology, Oncology and Other
Therapeutic Areas for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 79: UK Current & Future Analysis for Superdisintegrants
by Product - Natural Superdisintegrants, Synthetic
Superdisintegrants and Other Products - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 80: UK Historic Review for Superdisintegrants by Product -
Natural Superdisintegrants, Synthetic Superdisintegrants and
Other Products Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019

Table 81: UK 15-Year Perspective for Superdisintegrants by
Product - Percentage Breakdown of Value Sales for Natural
Superdisintegrants, Synthetic Superdisintegrants and Other
Products for the Years 2012, 2020 & 2027

Table 82: UK Current & Future Analysis for Superdisintegrants
by Therapeutic Area - Gastrointestinal, Cardiovascular,
Neurology, Oncology and Other Therapeutic Areas - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 83: UK Historic Review for Superdisintegrants by
Therapeutic Area - Gastrointestinal, Cardiovascular, Neurology,
Oncology and Other Therapeutic Areas Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 84: UK 15-Year Perspective for Superdisintegrants by
Therapeutic Area - Percentage Breakdown of Value Sales for
Gastrointestinal, Cardiovascular, Neurology, Oncology and Other
Therapeutic Areas for the Years 2012, 2020 & 2027

SPAIN
Table 85: Spain Current & Future Analysis for
Superdisintegrants by Product - Natural Superdisintegrants,
Synthetic Superdisintegrants and Other Products - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 86: Spain Historic Review for Superdisintegrants by
Product - Natural Superdisintegrants, Synthetic
Superdisintegrants and Other Products Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 87: Spain 15-Year Perspective for Superdisintegrants by
Product - Percentage Breakdown of Value Sales for Natural
Superdisintegrants, Synthetic Superdisintegrants and Other
Products for the Years 2012, 2020 & 2027

Table 88: Spain Current & Future Analysis for
Superdisintegrants by Therapeutic Area - Gastrointestinal,
Cardiovascular, Neurology, Oncology and Other Therapeutic Areas -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 89: Spain Historic Review for Superdisintegrants by
Therapeutic Area - Gastrointestinal, Cardiovascular, Neurology,
Oncology and Other Therapeutic Areas Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 90: Spain 15-Year Perspective for Superdisintegrants by
Therapeutic Area - Percentage Breakdown of Value Sales for
Gastrointestinal, Cardiovascular, Neurology, Oncology and Other
Therapeutic Areas for the Years 2012, 2020 & 2027

RUSSIA
Table 91: Russia Current & Future Analysis for
Superdisintegrants by Product - Natural Superdisintegrants,
Synthetic Superdisintegrants and Other Products - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 92: Russia Historic Review for Superdisintegrants by
Product - Natural Superdisintegrants, Synthetic
Superdisintegrants and Other Products Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 93: Russia 15-Year Perspective for Superdisintegrants by
Product - Percentage Breakdown of Value Sales for Natural
Superdisintegrants, Synthetic Superdisintegrants and Other
Products for the Years 2012, 2020 & 2027

Table 94: Russia Current & Future Analysis for
Superdisintegrants by Therapeutic Area - Gastrointestinal,
Cardiovascular, Neurology, Oncology and Other Therapeutic Areas -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 95: Russia Historic Review for Superdisintegrants by
Therapeutic Area - Gastrointestinal, Cardiovascular, Neurology,
Oncology and Other Therapeutic Areas Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 96: Russia 15-Year Perspective for Superdisintegrants by
Therapeutic Area - Percentage Breakdown of Value Sales for
Gastrointestinal, Cardiovascular, Neurology, Oncology and Other
Therapeutic Areas for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 97: Rest of Europe Current & Future Analysis for
Superdisintegrants by Product - Natural Superdisintegrants,
Synthetic Superdisintegrants and Other Products - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 98: Rest of Europe Historic Review for Superdisintegrants
by Product - Natural Superdisintegrants, Synthetic
Superdisintegrants and Other Products Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 99: Rest of Europe 15-Year Perspective for
Superdisintegrants by Product - Percentage Breakdown of Value
Sales for Natural Superdisintegrants, Synthetic
Superdisintegrants and Other Products for the Years 2012, 2020 &
2027

Table 100: Rest of Europe Current & Future Analysis for
Superdisintegrants by Therapeutic Area - Gastrointestinal,
Cardiovascular, Neurology, Oncology and Other Therapeutic Areas -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 101: Rest of Europe Historic Review for
Superdisintegrants by Therapeutic Area - Gastrointestinal,
Cardiovascular, Neurology, Oncology and Other Therapeutic Areas
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019

Table 102: Rest of Europe 15-Year Perspective for
Superdisintegrants by Therapeutic Area - Percentage Breakdown
of Value Sales for Gastrointestinal, Cardiovascular, Neurology,
Oncology and Other Therapeutic Areas for the Years 2012, 2020 &
2027

ASIA-PACIFIC
Table 103: Asia-Pacific Current & Future Analysis for
Superdisintegrants by Geographic Region - Australia, India,
South Korea and Rest of Asia-Pacific Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027

Table 104: Asia-Pacific Historic Review for Superdisintegrants
by Geographic Region - Australia, India, South Korea and Rest
of Asia-Pacific Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019

Table 105: Asia-Pacific 15-Year Perspective for
Superdisintegrants by Geographic Region - Percentage Breakdown
of Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027

Table 106: Asia-Pacific Current & Future Analysis for
Superdisintegrants by Product - Natural Superdisintegrants,
Synthetic Superdisintegrants and Other Products - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 107: Asia-Pacific Historic Review for Superdisintegrants
by Product - Natural Superdisintegrants, Synthetic
Superdisintegrants and Other Products Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 108: Asia-Pacific 15-Year Perspective for
Superdisintegrants by Product - Percentage Breakdown of Value
Sales for Natural Superdisintegrants, Synthetic
Superdisintegrants and Other Products for the Years 2012, 2020 &
2027

Table 109: Asia-Pacific Current & Future Analysis for
Superdisintegrants by Therapeutic Area - Gastrointestinal,
Cardiovascular, Neurology, Oncology and Other Therapeutic Areas -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 110: Asia-Pacific Historic Review for Superdisintegrants
by Therapeutic Area - Gastrointestinal, Cardiovascular,
Neurology, Oncology and Other Therapeutic Areas Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 111: Asia-Pacific 15-Year Perspective for
Superdisintegrants by Therapeutic Area - Percentage Breakdown
of Value Sales for Gastrointestinal, Cardiovascular, Neurology,
Oncology and Other Therapeutic Areas for the Years 2012, 2020 &
2027

AUSTRALIA
Table 112: Australia Current & Future Analysis for
Superdisintegrants by Product - Natural Superdisintegrants,
Synthetic Superdisintegrants and Other Products - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 113: Australia Historic Review for Superdisintegrants by
Product - Natural Superdisintegrants, Synthetic
Superdisintegrants and Other Products Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 114: Australia 15-Year Perspective for Superdisintegrants
by Product - Percentage Breakdown of Value Sales for Natural
Superdisintegrants, Synthetic Superdisintegrants and Other
Products for the Years 2012, 2020 & 2027

Table 115: Australia Current & Future Analysis for
Superdisintegrants by Therapeutic Area - Gastrointestinal,
Cardiovascular, Neurology, Oncology and Other Therapeutic Areas -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 116: Australia Historic Review for Superdisintegrants by
Therapeutic Area - Gastrointestinal, Cardiovascular, Neurology,
Oncology and Other Therapeutic Areas Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 117: Australia 15-Year Perspective for Superdisintegrants
by Therapeutic Area - Percentage Breakdown of Value Sales for
Gastrointestinal, Cardiovascular, Neurology, Oncology and Other
Therapeutic Areas for the Years 2012, 2020 & 2027

INDIA
Table 118: India Current & Future Analysis for
Superdisintegrants by Product - Natural Superdisintegrants,
Synthetic Superdisintegrants and Other Products - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 119: India Historic Review for Superdisintegrants by
Product - Natural Superdisintegrants, Synthetic
Superdisintegrants and Other Products Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 120: India 15-Year Perspective for Superdisintegrants by
Product - Percentage Breakdown of Value Sales for Natural
Superdisintegrants, Synthetic Superdisintegrants and Other
Products for the Years 2012, 2020 & 2027

Table 121: India Current & Future Analysis for
Superdisintegrants by Therapeutic Area - Gastrointestinal,
Cardiovascular, Neurology, Oncology and Other Therapeutic Areas -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 122: India Historic Review for Superdisintegrants by
Therapeutic Area - Gastrointestinal, Cardiovascular, Neurology,
Oncology and Other Therapeutic Areas Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 123: India 15-Year Perspective for Superdisintegrants by
Therapeutic Area - Percentage Breakdown of Value Sales for
Gastrointestinal, Cardiovascular, Neurology, Oncology and Other
Therapeutic Areas for the Years 2012, 2020 & 2027

SOUTH KOREA
Table 124: South Korea Current & Future Analysis for
Superdisintegrants by Product - Natural Superdisintegrants,
Synthetic Superdisintegrants and Other Products - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 125: South Korea Historic Review for Superdisintegrants
by Product - Natural Superdisintegrants, Synthetic
Superdisintegrants and Other Products Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 126: South Korea 15-Year Perspective for
Superdisintegrants by Product - Percentage Breakdown of Value
Sales for Natural Superdisintegrants, Synthetic
Superdisintegrants and Other Products for the Years 2012, 2020 &
2027

Table 127: South Korea Current & Future Analysis for

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05960207/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001